Torrid Holdings (CURV) CFO receives large RSU and stock option grants

Rhea-AI Filing Summary

Torrid Holdings Inc. Chief Financial Officer Paula Dempsey reported equity compensation awards rather than market trades. She received 137,796 shares of Common Stock as restricted stock units that vest in four equal 25% installments each March 16 from 2027 through 2030, conditioned on continued employment. She also received an option to purchase 246,479 shares of Common Stock at an exercise price of $1.27 per share, expiring on March 16, 2036, which vests in equal 25% tranches on March 16 of 2027, 2028, 2029, and 2030. Following these awards, her direct Common Stock holdings increased to 277,598 shares, and she holds the newly granted option for 246,479 underlying shares.

Insights

Equity Compensation Analyst

Routine equity grants increase CFO’s stock and option exposure.

The filing shows equity-based compensation for Torrid’s CFO, not open-market buying or selling. She was granted 137,796 restricted stock units and options for 246,479 shares at $1.27, expiring in 2036.

Both awards vest in four annual 25% installments on March 16 from 2027 through 2030, subject to continued employment. This structure encourages longer-term retention and aligns the CFO’s incentives with future share performance, while not signaling any immediate view on the stock price.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Dempsey Paula

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Option to purchase shares	246,479	$0.00	--
Grant/Award	Common Stock	137,796	$0.00	--

Holdings After Transaction: Option to purchase shares — 246,479 shares (Direct); Common Stock — 277,598 shares (Direct)

Footnotes (1)

1. Represents restricted stock units, which will vest annually in substantially equal 25% installments on March 16 2027, March 16 2028, March 16 2029 and March 16 2030, respectively, subject to the reporting person's continued employment through the applicable vesting date. Represents options to purchase shares that will start vesting on March 16, 2027 and become exercisable in substantially equal 25% installments on March 16, 2027, March 16, 2028, March 16, 2029 and March 16, 2030, respectively, subject to the reporting person's continued employment through the applicable vesting date.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Dempsey Paula

(Last) (First) (Middle)

18501 E SAN JOSE AVE.

(Street)

CITY OF INDUSTRY CALIFORNIA 91748

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Torrid Holdings Inc. [ CURV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/16/2026		A		137,796(1)	A	$0	277,598	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to purchase shares	$1.27	03/16/2026		A		246,479		(2)	03/16/2036	Common Stock	246,479	$0	246,479	D

Explanation of Responses:

1. Represents restricted stock units, which will vest annually in substantially equal 25% installments on March 16 2027, March 16 2028, March 16 2029 and March 16 2030, respectively, subject to the reporting person's continued employment through the applicable vesting date.

2. Represents options to purchase shares that will start vesting on March 16, 2027 and become exercisable in substantially equal 25% installments on March 16, 2027, March 16, 2028, March 16, 2029 and March 16, 2030, respectively, subject to the reporting person's continued employment through the applicable vesting date.

Remarks:

	/s/ Bridgett C. Zeterberg, as Attorney-in-Fact for Paula Dempsey	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Torrid Holdings (CURV) CFO Paula Dempsey report in this Form 4?

She reported equity compensation grants, not market trades. The filing shows new restricted stock units and stock options awarded as part of her compensation, increasing her share and option exposure to Torrid Holdings over a multi-year vesting schedule.

How many restricted stock units did the Torrid (CURV) CFO receive?

Paula Dempsey received 137,796 restricted stock units of Torrid Holdings Common Stock. These units represent shares that will be delivered over time, provided she remains employed through the scheduled vesting dates between 2027 and 2030.

What stock options were granted to the Torrid (CURV) CFO and at what price?

She was granted options to purchase 246,479 shares of Torrid Holdings Common Stock at an exercise price of $1.27 per share. These options expire on March 16, 2036, giving her a long-dated opportunity to buy shares at that price once vested.

What is the vesting schedule for the Torrid (CURV) CFO equity awards?

Both the restricted stock units and options vest in four equal 25% installments. Vesting occurs annually on March 16 of 2027, 2028, 2029, and 2030, and each installment requires her continued employment through the relevant vesting date.

How many Torrid (CURV) shares does the CFO hold after these grants?

After the grants, Paula Dempsey directly holds 277,598 shares of Torrid Holdings Common Stock. In addition, she holds an option covering 246,479 underlying shares, which can be exercised at $1.27 per share once the option vests over time.

Does this Torrid (CURV) Form 4 show the CFO buying or selling stock in the market?

No, the Form 4 reflects compensation-related awards only. The transactions are coded as grants or awards of restricted stock units and stock options, with a transaction price of zero, rather than open-market purchases or sales of Torrid Holdings shares.